Corps Capital Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$350K Buy
292
+59
+25% +$60.3K 0.28% 68
2026
Q1
$214K Hold
233
0.19% 85
2025
Q4
$250K Buy
+233
New +$223K 0.26% 72

Other funds holding LLY

Corps Capital Advisors's LLY Position: Q2 2026 in Review

Corps Capital Advisors increased its Eli Lilly (LLY) stake by 25% in Q2 2026, buying an estimated $60.3K and bringing the position to 292 shares worth $350K. The position accounts for 0.28% of the portfolio, ranked #68.

Corps Capital Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Corps Capital Advisors held 292 shares of Eli Lilly worth $350K as of Q2 2026.
  • Corps Capital Advisors bought 59 Eli Lilly shares in Q2 2026, an estimated $60.3K.
  • Eli Lilly made up 0.28% of Corps Capital Advisors's portfolio in Q2 2026, its #68 holding.
  • Corps Capital Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Corps Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.